Search

everythinglearnresearchcommunity

for

Search:↓

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Lipedematous scalp is mainly caused by an increase in fat tissue under the skin and is different from lipedematous alopecia.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Early hair loss may indicate prostate issues.

In vivo confocal scanning laser microscopy is an effective, non-invasive way to study and measure new hair growth after skin injury in mice.

Oral steroids may effectively treat recurrent intussusception in children with ILH, possibly avoiding surgery.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

AR gene not major factor in female hair loss; different from male hair loss.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Finasteride effectively treats BPH and hair loss but may cause sexual side effects.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Spironolactone may help reduce hair loss in androgenic alopecia.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Many women with hard-to-treat acne also have PCOS.

The document concludes that more research is needed to fully understand the causes of PCOS.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.